Last reviewed · How we verify
additional tissue samples
At a glance
| Generic name | additional tissue samples |
|---|---|
| Sponsor | Assistance Publique Hopitaux De Marseille |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma (PHASE2)
- Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
- MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) (PHASE2)
- Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants
- Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
- Synovial Tissue as a Biomarker in the Early Management of Osteoarthritis (NA)
- Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease
- Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |